Learn how Logi Options+ lets you control and personalize your Logitech devices on a Windows 11/10 PC. Explore features like ...

The MarketWatch News Department was not involved in the creation of this content. Milestone underscores continued momentum in commercial rollout and accelerating adoption of neuroimmune modulation as ...

Setpoint’s acquisition of inTENT Fulfillment will add experienced leaders and broaden ratings agency approvals for its asset-backed finance platform. AI Summary Setpoint, an operating system for asset ...

SetPoint Medical is offering patients with the autoimmune disorder rheumatoid arthritis something close to a cure. The company’s SetPoint System—which was FDA approved in July—is a small neck implant ...

NEW HYDE PARK, N.Y. & VALENCIA, Calif.--(BUSINESS WIRE)--Northwell Health and SetPoint Medical today announced that Northwell is the first health system to provide the recent U.S. Food and Drug ...

Fresh after getting the green light from the U.S. Food and Drug Administration, SetPoint Medical raises $140 million to market and distribute its rheumatoid arthritis treatment. SetPoint Medical Chief ...

SetPoint Medical, a Valencia-based company dedicated to developing therapies for people living with chronic autoimmune diseases, raised $140 million in private financing that includes $25 million in ...

Shortly after obtaining a green light from the FDA, SetPoint Medical announced $140 million in new funding to juice the commercialization of its neuromodulation implant for rheumatoid arthritis. The ...

SetPoint Medical has raised $140 million. This includes $25 million in the second tranche of its Series C financing, as well as $115 million in its Series D financing, co-led by Elevage Medical ...

The SetPoint System is indicated for patients who are not adequately managed by -- or cannot tolerate -- existing advanced RA therapies, such as biological and targeted synthetic disease-modifying ...

Northwell Health was one of many who conducted a pioneering clinical trial to treat rheumatoid arthritis through a chip implanted on the vagus nerve. The first technology of its kind yielded ...

VALENCIA, Calif., July 31, 2025--(BUSINESS WIRE)--SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today announced that the U.S. Food ...